Abingdon, United Kingdom

Arnaud Techine

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Immunocore Limited. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arnaud Techine. Retrieved from https://idiyas.com/inventor/arnaud-techine

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arnaud Techine: Innovator in Binding Molecules

Introduction

Arnaud Techine is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of biotechnology, particularly in the development of binding molecules that have potential applications in treating malignant diseases.

Latest Patents

Arnaud holds a patent for binding molecules that comprise T cell receptor (TCR) variable domains. This invention focuses on molecules that can bind to a PIWIL1 peptide-HLA complex, showcasing his innovative approach to addressing complex medical challenges. His patent is a testament to his expertise and dedication to advancing medical science. He has 1 patent to his name.

Career Highlights

Arnaud Techine is currently employed at Immunocore Limited, a company known for its pioneering work in immunotherapy. His role at Immunocore allows him to collaborate with other talented professionals in the field, further enhancing his contributions to biotechnology.

Collaborations

Some of his notable coworkers include Nicole Mai and Jakub Jaworski. Their collective efforts contribute to the innovative environment at Immunocore Limited.

Conclusion

Arnaud Techine's work in binding molecules represents a significant advancement in the treatment of malignant diseases. His innovative spirit and collaboration with talented colleagues position him as a key figure in the biotechnology sector.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…